Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. KEQU
KEQU logo

KEQU Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
42.050
Open
42.050
VWAP
42.05
Vol
4.00
Mkt Cap
120.53M
Low
42.050
Amount
168.20
EV/EBITDA(TTM)
6.67
Total Shares
2.87M
EV
172.88M
EV/OCF(TTM)
19.95
P/S(TTM)
0.44
Kewaunee Scientific Corporation is engaged in designing, manufacturing, and installation of laboratory, healthcare and technical furniture products. The Company’s products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, ultralow freezers, and epoxy resin work surfaces and sinks. Its segments include Domestic and International. The Domestic segment designs, manufactures, and installs scientific and technical furniture. The International segment consists of foreign subsidiaries. The Company's products are sold primarily through purchase orders and contracts submitted by customers through its dealers and its subsidiaries, and a national distributor. It has three manufacturing facilities that are located in Statesville serving the domestic and international markets, and one manufacturing facility is located in Bangalore, India serving the local, Asian, and African markets.
Show More

Events Timeline

(ET)
2025-09-10
16:11:48
Kewaunee Scientific announces Q1 EPS of $1.04, up from 74 cents last year
select
2025-09-10
16:11:16
Kewaunee Scientific announces Q1 EPS of $1.04, up from 74 cents last year
select
2025-03-12 (ET)
2025-03-12
17:11:13
Kewaunee Scientific announces amendment to share repurchase program
select
2024-12-11 (ET)
2024-12-11
15:07:52
Kewaunee Scientific reports Q3 EPS $1.01 vs. 93c last year
select
2024-09-11 (ET)
2024-09-11
16:50:12
Kewaunee Scientific reports Q1 EPS 74c vs. 86c last year
select

News

PRnewswire
1.0
03-03PRnewswire
Kewaunee to Showcase at 2026 analytica Tradeshow in Munich
  • Exhibition Opportunity: Kewaunee Scientific Corporation will attend the analytica tradeshow in Munich from March 24-27, 2026, showcasing its laboratory infrastructure and safety solutions alongside its recently acquired subsidiary, Nu Aire, and is expected to attract over 30,000 professionals, enhancing brand visibility and market influence.
  • Product Portfolio Showcase: The event will feature a comprehensive product lineup from Kewaunee and Nu Aire, including biological safety cabinets and CO2 incubators, aimed at addressing modern laboratory needs for safety and efficiency, thereby enhancing customer trust and driving sales growth.
  • Industry Partnerships: Kewaunee will collaborate with its European market partner, ibs tecnomara, to demonstrate how coordinated infrastructure and containment solutions can enhance laboratory performance, further solidifying its leadership position in the industry.
  • Strategic Commitment: Kewaunee's CEO, Thomas D. Hull III, emphasized that the tradeshow represents a vital opportunity to connect with global laboratory users and partners, showcasing the company's commitment to supporting laboratory projects throughout their lifecycle, indicating potential for future business growth.
Yahoo Finance
9.5
02-25Yahoo Finance
Kewaunee Scientific to Release Q3 FY2026 Financial Results
  • Earnings Release Schedule: Kewaunee Scientific Corporation plans to announce its third quarter fiscal year 2026 financial results on March 11, 2026, after market close, which is expected to provide investors with insights into the company's financial health and operational performance.
  • Company Overview: Founded in 1906, Kewaunee is a global leader in the design, manufacture, and installation of laboratory, healthcare, and technical furniture products, including steel and wood casework and fume hoods, serving both domestic and international markets.
  • Acquisition Details: The recent acquisition of Nu Aire, a manufacturer of biological safety cabinets and ultra-low freezers, enhances Kewaunee's product portfolio, thereby strengthening its competitive position in the laboratory equipment market.
  • Global Business Presence: Kewaunee operates sales offices in the U.S., India, Saudi Arabia, and Singapore, with manufacturing facilities in Statesville and Bangalore, reflecting its strategic focus on global market expansion and production capabilities.
NASDAQ.COM
9.5
01-22NASDAQ.COM
Agnico Eagle Mines Stock Rises 63.4% Over Six Months
  • Stock Performance: Agnico Eagle's shares have surged 63.4% over the past six months, outperforming the Zacks Mining - Gold industry, which gained 85.9%, indicating its relative strength in the market.
  • Earnings Estimates Rising: The company's earnings estimates for Q4 2025 have been increasing over the past month, reflecting growing market confidence in its future growth potential, particularly with cost savings expected from the Kittila expansion project.
  • Strengthened Market Position: The merger with Kirkland Lake Gold has established Agnico Eagle as the industry's highest-quality senior gold producer, with a robust pipeline of development and exploration projects ensuring sustainable growth.
  • Diversification Strategy: By maintaining prudent debt management and financial flexibility, the company mitigates risks, with higher gold prices expected to further enhance its margins, thereby boosting investor confidence.
NASDAQ.COM
9.5
01-22NASDAQ.COM
Agnico Eagle Mines (AEM) Q4 Earnings Outlook Improves, Shares Up 63.4% Over Six Months
  • Earnings Outlook Improvement: Agnico Eagle Mines has seen its stock rise 63.4% over the past six months, outperforming the Zacks Mining - Gold industry’s 85.9% gain, reflecting market optimism regarding its Q4 earnings estimates.
  • Project Expansion and Acquisitions: The company is enhancing its market position through the Kittila expansion project and acquisitions like Hope Bay, along with the merger with Kirkland Lake Gold, which are expected to drive future production growth and cost savings.
  • Enhanced Financial Flexibility: Agnico Eagle mitigates risks through prudent debt management and strategic diversification, while higher gold prices are anticipated to boost the company's margins, further strengthening its financial stability.
  • Sustainable Growth Pipeline: The merged entity now possesses an extensive pipeline of development and exploration projects, ensuring potential for sustainable growth that aligns with industry demand for high-quality gold producers.
PRnewswire
9.5
2025-12-10PRnewswire
Kewaunee Reports 46.8% Sales Growth in Q2 FY2026
  • Significant Sales Growth: Kewaunee reported sales of $70.1 million for Q2 FY2026, reflecting a 46.8% increase from $47.8 million in the same quarter last year, indicating strong market demand and operational performance.
  • Strong Domestic Performance: Domestic sales reached $55.2 million, up 51.7% year-over-year, demonstrating resilience despite lower manufacturing volumes in laboratory construction, with Nu Aire's strong performance offsetting some of the challenges, highlighting the success of the company's diversification strategy.
  • Continued International Growth: International sales amounted to $14.9 million, a 31.0% increase from $11.4 million in the prior year, primarily driven by the delivery of large projects booked in previous periods, showcasing the company's expansion potential in global markets.
  • Improved Financial Position: As of October 31, 2025, the company had cash on hand of $13.7 million, down from $17.2 million on April 30, but working capital increased to $67.8 million, indicating financial stability amid ongoing investments and growth initiatives.
NASDAQ.COM
9.5
2025-12-10NASDAQ.COM
Kewaunee Scientific Corporation Reports Decrease in Q2 Earnings
  • Profit Decline: Kewaunee Scientific Corporation reported a profit of $2.538 million for the second quarter, down from $4.204 million the previous year.

  • Earnings Per Share: The earnings per share (EPS) decreased to $0.82 from $1.41 year-over-year.

  • Revenue Growth: The company's revenue increased by 46.8% to $70.096 million, compared to $47.764 million last year.

  • Earnings Overview: Key figures include earnings of $2.538 million, EPS of $0.82, and revenue of $70.096 million for the current quarter.

Valuation Metrics

The current forward P/E ratio for Kewaunee Scientific Corp (KEQU.O) is 17.36, compared to its 5-year average forward P/E of 12.84. For a more detailed relative valuation and DCF analysis to assess Kewaunee Scientific Corp's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PE
12.84
Current PE
17.36
Overvalued PE
19.97
Undervalued PE
5.71

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average EV/EBITDA
8.72
Current EV/EBITDA
13.76
Overvalued EV/EBITDA
13.14
Undervalued EV/EBITDA
4.30

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
0.50
Current PS
0.68
Overvalued PS
0.78
Undervalued PS
0.22

Financials

AI Analysis
Annual
Quarterly

Whales Holding KEQU

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Kewaunee Scientific Corp (KEQU) stock price today?

The current price of KEQU is 42.05 USD — it has increased 0

What is Kewaunee Scientific Corp (KEQU)'s business?

Kewaunee Scientific Corporation is engaged in designing, manufacturing, and installation of laboratory, healthcare and technical furniture products. The Company’s products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, ultralow freezers, and epoxy resin work surfaces and sinks. Its segments include Domestic and International. The Domestic segment designs, manufactures, and installs scientific and technical furniture. The International segment consists of foreign subsidiaries. The Company's products are sold primarily through purchase orders and contracts submitted by customers through its dealers and its subsidiaries, and a national distributor. It has three manufacturing facilities that are located in Statesville serving the domestic and international markets, and one manufacturing facility is located in Bangalore, India serving the local, Asian, and African markets.

What is the price predicton of KEQU Stock?

Wall Street analysts forecast KEQU stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for KEQU is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Kewaunee Scientific Corp (KEQU)'s revenue for the last quarter?

Kewaunee Scientific Corp revenue for the last quarter amounts to 70.10M USD, increased 46.75

What is Kewaunee Scientific Corp (KEQU)'s earnings per share (EPS) for the last quarter?

Kewaunee Scientific Corp. EPS for the last quarter amounts to 0.82 USD, decreased -18.81

How many employees does Kewaunee Scientific Corp (KEQU). have?

Kewaunee Scientific Corp (KEQU) has 1239 emplpoyees as of March 11 2026.

What is Kewaunee Scientific Corp (KEQU) market cap?

Today KEQU has the market capitalization of 120.53M USD.